MLCI Earnings

MLCI reported its earnings on 2025-11-13, showcasing a revenue of 11.43M against an estimate of 20.12M, resulting in a -43.21% surprise. The EPS was 0, surpassing the expected 0 by 0% . The stock experienced a -2.16% price change on the earnings day and a -3.24% change over the next five days, reflecting market reactions to the results.

Following MLCI's earnings announcement on 2025-11-13, the stock price moved by -2.16% on the day of the release. Over the subsequent five days, it saw a -3.24% change. Historically, MLCI's stock price tends to shift by an average of -6.48% in the 10 days leading up to earnings and -1.27% in the 10 days following, providing insight into potential market.

For , analysts estimate MLCI’s annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates Go Down by -11.94% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between MLCI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved Go Down by -11.94% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MLCI's stock price typically moves by -6.48% in the 10 days before its earnings and -1.27% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.

The earnings call reveals several concerning financial metrics, including a net loss increase and revenue decline. While management offers optimistic guidance for future FRE and SRE growth, the current financial health is weak, with significant impairments and lower income. The Q&A section highlights uncertainties and vague responses from management, especially regarding M&A and market engagement strategies. The tender offer and share repurchase plan provide some positive sentiment, but overall, the financial performance and lack of clear strategic direction suggest a negative outlook.